← Back to Search

Virtual Reality Therapy for Stroke Recovery

N/A

Recruiting

Led By Anouk Lamontagne, PhD

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

People with chronic stroke and persistent deficits in walking / visual-perceptual / cognitive capacities

Ability to walk independently with/without walking aids for at least 1 min at 0.4-0.9 m/s

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (week0), pre-intervention (week4), post-intervention (week8) and follow-up (week12)

Awards & highlights

Study Summary

This trial will test a new VR rehabilitation intervention to help stroke survivors ambulate better in their community. The study will assess feasibility, safety, and efficacy of the intervention.

Who is the study for?

This trial is for chronic stroke survivors aged 40-74 with walking, cognitive, or visual-perceptual deficits. They must have had their first-ever unilateral stroke 9-24 months prior and be able to walk independently at a certain speed. Participants need normal vision/hearing (with aids if necessary) and mild-to-moderate hemiparesis.Check my eligibility

What is being tested?

The study tests a new intervention combining virtual reality (VR) and field training aimed at improving community walking skills in stroke survivors. It involves VR exercises in a simulated environment and supervised outdoor walking practice over a four-week program.See study design

What are the potential side effects?

Potential side effects may include discomfort from wearing VR goggles, motion sickness from the virtual environment, fatigue due to intensive training, or stress on affected limbs during ambulation practice.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have long-term effects from a stroke affecting my walking, vision, or thinking.

Select...

I can walk on my own with or without help for at least 1 minute.

Select...

I have some weakness on one side of my body but can still move.

Select...

I am between 40 and 74 years old.

Select...

My vision and hearing are normal or corrected to normal.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (week0), pre-intervention (week4), post-intervention (week8) and follow-up (week12)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (week0), pre-intervention (week4), post-intervention (week8) and follow-up (week12)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week0), pre-intervention (week4), post-intervention (week8) and follow-up (week12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in the Six Minute Walk Test (6MWT) at Follow-up

Post-intervention change in the Six Minute Walk Test (6MWT)

Secondary outcome measures

5m Walk Test

Activities-Specific Balance Confidence Scale

Assessment of Life Habits (Life-H: mobility and community life domains)

+3 more

Other outcome measures

Acceptability of the intervention

Adherence to intervention

Cadence

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Virtual Reality and Field Practice Training (VRFT)Experimental Treatment1 Intervention

Participants will engage in a 4-week VRFT intervention that comprises of 1-hour training sessions, 3 times/week.

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Jewish Rehabilitation HospitalOTHER

5 Previous Clinical Trials

740 Total Patients Enrolled

2 Trials studying Stroke

170 Patients Enrolled for Stroke

Laval UniversityOTHER

417 Previous Clinical Trials

172,232 Total Patients Enrolled

4 Trials studying Stroke

1,915 Patients Enrolled for Stroke

Integrated University Health and Social Services Center of the Capitale-NationaleOTHER

4 Previous Clinical Trials

543 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What potential outcomes is this medical experiment looking to realize?

"The primary aim of this experiment, assessed over a 4-week pre-intervention period and 8 week post-intervention period, is to gauge the effectivity of the intervention on participants' 6MWT score. Auxiliary objectives include an Activities-Specific Balance Confidence Scale (a 16 question self assessment measuring balance security while performing assorted activities), Trip Activity Log (questionnaire log recording trips and walking related activity in community spaces) as well as Life Habits Mobility & Community Life Domains Evaluation (assessment assessing mobility and community life habits)."

Answered by AI

Does this research study currently have room for enrollment?

"Affirmative, the data on clinicaltrials.gov supports that this experiment is currently enrolling subjects. Initially posted on April 1st 2021 and most recently revised on August 23rd 2022, this trial requires 40 individuals across 2 sites to participate."

Answered by AI

Are elderly participants accepted in this investigation?

"Following the guidelines of this research project, enrolment is restricted to those aged between 40 and 74."

Answered by AI

What is the cohort size of this research experiment?

"Affirmative. Clinicaltrials.gov has records of this medical trial, which was first posted on April 1st 2021, actively looking for participants at 2 sites with a goal to recruit 40 patients."

Answered by AI

Is it possible for me to become a participant in this experiment?

"This trial requires 40 participants aged between 40 and 74 who have had a stroke. Candidates must satisfy both criteria to be considered for entry into the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Virtual Reality and Field Training to Enhance Community Walking After Stroke

Anouk Lamontagne 2021. "Virtual Reality and Field Training to Enhance Community Walking After Stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04559373.

All > Stroke